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Abstract
Background: The sperm penetration assay (SPA) is used to predict the fertilizing capacity of
sperm. Thus, some programs rely on SPA scores to formulate insemination plans in conjunction
with in-vitro fertilization (IVF) cycles. The purpose of this study was to evaluate if a relationship
exists between SPA scores and polyspermy rates during conventional IVF cycles.
Methods: A total of 1350 consecutive IVF patients using conventional IVF insemination were
evaluated in the study. Oocytes were inseminated three hours post-retrieval by the addition of
150,000 to 300,000 progressively motile sperm. Approximately 18 hours after insemination, the
oocytes were evaluated for fertilization by the visualization of pronuclei. The presence of three or
more pronuclei was indicative of polyspermy. Polyspermy rates, fertilization success, embryo
quality, and pregnancy rates were analyzed retrospectively to evaluate their relationship with SPA
score, count, motility, number of progressively motile sperm inseminated, oocyte pre-insemination
incubation time, patient age, and diagnosis.
Results: A significant positive relationship was observed between SPA score and polyspermy rate
(rs = 0.10, p < 0.05). Patients with a normal SPA score had significantly higher polyspermy rates
than those with abnormal SPA scores (6.3% ± 1.5% vs. 2.0% ± 0.7%, p < 0.05). Fertilization
percentage was significantly lower in the group with severely abnormal SPA scores versus all other
SPA groups (57.5% ± 2.1% vs. 70.2% ± 1.3%, p < 0.005). Although embryo quality was not affected,
both clinical pregnancy and implantation rates improved slightly as SPA score increased. In addition,
there was a decrease in the rate of spontaneous abortion as SPA score increased.
Conclusions: These data indicate SPA score is positively correlated with polyspermy rates and
IVF fertilization percentage. Additionally, there is a slight increase in clinical pregnancy rates, and
embryo implantation rates with increased SPA. Furthermore, there is a slight decrease in
spontaneous abortions rates related to increased SPA.
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Findings
The sperm penetration assay (SPA) is used to evaluate the
fertilizing capacity of human spermatozoa [1]. Some in-
vitro fertilization (IVF) programs rely on the SPA to for-
mulate their insemination plans in conjunction with IVF
cycles [1,2]. Couples with normal SPA scores normally
undergo conventional IVF insemination in contrast with
intracytoplasmic sperm injection (ICSI), which is used for
those with a diminished SPA.
Over the past decades success rates have steadily improved
for human IVF embryo transfer programs. Recent
advances in ovulation induction, micromanipulation,
culturing conditions, and media formulations have fos-
tered a technological revolution for IVF leading into the
21'st century (Pool, 2002). However, many common
problems still remain.
One common problem associated with conventional IVF
insemination is polyspermic fertilization when more than
one sperm successfully penetrates and fertilizes the
oocyte. These pre-embryos are considered abnormal and
typically discarded. Thus, increased rates of polyspermy
ultimately result in a reduced number of embryos.
Studies have been conducted that evaluate the factors
associated with human IVF polyspermy [3-5]. However,
most of the reports are based on data over a decade old.
Recent improvements in IVF techniques may alter these
relationships. Furthermore, no study has evaluated the
relationship between sperm SPA score and incidence of
polyspermy in human IVF.
The purpose of this study was to evaluate if a relationship
exists between SPA scores and polyspermy rates during
IVF cycles utilizing conventional insemination. We also
evaluated the relationship between SPA score and fertili-
zation rate, embryo quality, and pregnancy rate.
After Institutional Review Board approval, we conducted
a retrospective study of 1350 consecutive IVF patients
using conventional IVF insemination. Intracytoplasmic
sperm injection (ICSI) patients were excluded from the
study. The fertilizing capacity of each patient was assessed
with the SPA. The SPA was performed on patients under-
going IVF using techniques previously described [6]. The
SPA was performed on patients less than sixty days prior
to the IVF cycle. The SPA score reflects the percentage of
eggs successfully penetrated by the patient's sperm. SPA
patients were stratified into 4 groups according to SPA
score (Group 1: severely abnormal SPA (< 10% penetra-
tion), n = 182; Group 2: abnormal SPA (10–19% penetra-
tion), n = 368; Group 3: normal SPA (20 – 29%
penetration), n = 404; Group 4: high-normal SPA (> 30%
penetration), n = 396).
During the IVF cycle ovarian stimulation was performed
using standard techniques of gonadotrophin-releasing
hormone (GnRH) agonist down-regulation combined
with controlled ovarian stimulation using a combination
of recombinant follicle stimulating hormone (rFSH) and
urinary-derived gonadotropin stimulation. Ovarian folli-
cles were aspirated using a trans-vaginal ultrasound-
guided needle.
Oocytes were inseminated three-hours post-retrieval by
the addition of 150,000 to 300,000 progressively motile
sperm. Approximately 18-hours post-insemination, the
oocytes were evaluated for fertilization by visualization of
pronuclei. The presence of three or more pronuclei was
indicative of polyspermy in which case the fertilized
oocyte was discarded. Embryos were cultured in HTF
medium and transferred 72-hours post-retrieval. Embryo
quality was assessed using a previously reported embryo
scoring system that took into account the number of cells
present and the level of cellular fragmentation [7].
Polyspermy rates, fertilization success, embryo quality,
and pregnancy rates were analyzed retrospectively with
respect to their relationship with SPA score. The correla-
tion between SPA score and polyspermy was conducted
using Spearman's correlation coefficient. Additionally,
polyspermy rates, fertilization percentage, and embryo
quality for the different SPA groups were analyzed for sta-
tistical difference using Kruskal-Wallis analysis. Lastly,
pregnancy rates in the different groups were evaluated
with a Chi-square analysis.
A significant positive relationship was observed between
SPA score and polyspermy rates in 1350 IVF patients
undergoing conventional IVF insemination (rs = 0.10, p <
0.05). Patients with normal SPA scores (Group 3) had sig-
nificantly elevated polyspermy rates over those with
severely abnormal SPA scores (6.3 ± 1.5 – 113/1,791 vs.
2.0 ± 0.7 – 20/1,020, p < 0.05, Table 1, please see file
"Table1-Aoki et al.doc", Additional file 1). Conventional
IVF fertilization rate was significantly lower in patients
with severely abnormal SPA (57.5 ± 2.1 – 1,135/1,974) vs.
all other patients (70.2 ± 1.3 – 8,519/12,135; p < 0.005,
Table 1, please see file "Table1-Aoki et al.doc", Additional
file 1).
Embryo quality showed no relationship to the SPA (Table
1, please see file "Table1-Aoki et al.doc" Additional file 1).
Clinical pregnancy and implantation rates were increased
in Group 4 (50.8% – 202/396 and 27.4% – 343/1255,
respectively) versus Group 1 (31.6% – 58/182 and 15.7%
– 96/612, respectively, p < 0.05) but no significant rela-
tionship between SPA and IVF outcome was observed
throughout the entire study population (Table 1, please
see file "Table1-Aoki et al.doc" Additional file 1). Simi-Journal of Experimental & Clinical Assisted Reproduction 2005, 2:3 http://www.jexpclinassistreprod.com/content/2/1/3
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larly, there was a decrease in the rate of spontaneous abor-
tion in Group 4 (14.7% – 30/202) versus Group 1 (31.3%
– 18/58), although no significant relationship was
observed within the entire population (Table 1, please see
file "Table1-Aoki et al.doc" Additional file 1).
No relationships were observed between IVF polyspermy
rates and maternal age, maternal diagnosis, amount of
progressively motile sperm added, sperm morphology,
ovarian stimulation protocol, or post-oocyte retrieval pre-
insemination incubation time. Additionally, confounder
analysis indicated the SPA groups were similar with
respect to paternal age, maternal age and IVF diagnosis.
Therefore, no standardization of the data with respect to
these variables was required.
This is the first report to correlate SPA score with IVF
polyspermy rates. Significantly elevated IVF polyspermy
rates were observed in patients with normal SPA scores.
Previous reports have established a relationship between
IVF polyspermy and oocyte age/maturation, state of the
zona pellucida, number of progressively motile sperm
used for insemination, oviductal cytokine expression, and
in-vitro culture conditions such as pH, temperature, and
media supplementation [5].
Unlike other reports, we did not find a relationship
between the number of progressively motile sperm used
for insemination and IVF polyspermy rates. This discrep-
ancy is most likely due to the narrow range of sperm
number we used for insemination (150,000 to 300,000)
compared with the studies of van der Ven et al. who used
500,000 to 1.5 *106 sperm [4]. Our results are consistent
with Ho et al. who found no relationship between these
variables [3]. However, the data still suggest minimizing
the number of sperm added for IVF insemination in
patients with increased SPA scores.
Poly-pronuclear formation in in-vitro fertilized eggs usu-
ally arises from polyspermic fertilization but may also be
a product of second polar body retention [8]. Thus, one
potential pitfall of associating poly-pronuclear fertilized
oocytes with polyspermy is the uncertainty related to sec-
ond polar body retention. However, a recent report
showed only a small percentage of fertilized oocytes with
three-pronuclei (2.5%) arise from second polar body
retention. The findings of this study validate our study
design of categorizing poly-pronuclear fertilized oocytes
as polyspermic. Moreover, we would expect the contribu-
tion of second polar body retention to be consistent
throughout the SPA groups negating any confounding
effects.
Consistent with other reports, the SPA was correlated with
fertilization percentage [1,6]. Furthermore, clinical preg-
nancy and implantation rates did show improvement in
patients with a high-normal SPA versus those with a
severely abnormal SPA. In addition, spontaneous abor-
tion rates were significantly different between these two
groups. This data strongly suggests ICSI may be an attrac-
tive alternative for patients with severely affected penetra-
tion ability.
Done correctly, the SPA provides a reliable assessment of
the fertilizing ability of human spermatozoa with very low
false negative rates (< 0.03%) and serves a valuable tool
for clinicians to treat infertility patients with the appropri-
ate modality [9]. The SPA is particularly useful in light of
recent concerns about ICSI and imprinting diseases [10-
12]. These concerns have led to the recommendation that
IVF clinicians should be careful to employ the technique
only when necessary and the SPA provides a prognostic
tool to appropriately make that decision. Based on these
findings, it may be valuable for individual IVF programs
to re-evaluate the clinical utility of SPA testing. The SPA
may prove valuable for clinicians to avoid increased
amounts of polyspermy and unnecessary wasting of
oocytes. Meanwhile, the SPA does not appear to be a reli-
able indicator of IVF embryo quality or pregnancy rates.
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